News

< Back

Board Member in the News: Nir Barzilai on the TAME Trials in Medium

On September 5, 2019, Medium elemental featured insights from AFAR expert Nir Barzilai, MD, on the potential of the AFAR-managed TAME Trials to transform healthspan through drugs like metformin to treat aging.

“Based on what scientists have already observed with diabetic and prediabetic patients taking metformin,” the article states, “Barzilai is confident the drug has a beneficial effect on the biological mechanisms underlying aging.”

On the TAME trials, the article says, “TAME mainly seeks to answer the question of whether metformin will help lengthen life and stave off disease.”

Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research Grant recipient, and a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, as well as the Director at the Institute for Aging Research and a distinguished Professor at the Albert Einstein College of Medicine.

Learn more about the TAME Trials, which AFAR will manage, here.

Read the article, “The Safe, Boring, and Extremely Cheap Drug That Could Cure Aging,” here.

More Recent News

View All News >
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Norman Volk, Former AFAR Board Member
In Memoriam: Norman Volk, Former AFAR Board Member
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors